Literature DB >> 24661267

Sexual life of Japanese patients with erectile dysfunction taking phosphodiesterase type 5 inhibitors: an Internet survey using the Psychological and Interpersonal Relationship Scales-Short Form questionnaire.

Akira Tsujimura1, Hiroshi Kiuchi, Tetsuji Soda, Kentaro Takezawa, Hidenobu Okuda, Shinichiro Fukuhara, Tetsuya Takao, Norio Nonomura, Yasushi Miyagawa.   

Abstract

OBJECTIVES: To investigate details of sexual function of erectile dysfunction in Japanese patients taking phosphodiesterase type 5 inhibitors.
METHODS: A Japanese version of the Psychological and Interpersonal Relationship Scales-Short Form was used to carry out a nationwide survey using the Internet. A total of 556 erectile dysfunction patients (age 30-70 years) who had been prescribed a phosphodiesterase type 5 inhibitor and had attempted sexual intercourse within the past 6 months were included in this survey. Scores were compared in relation to the phosphodiesterase type 5 inhibitors most frequently taken within the past 6 months.
RESULTS: In the subdomains of self-confidence and spontaneity of the Psychological and Interpersonal Relationship Scales-Short Form, scores for vardenafil and tadalafil were significantly higher than those for sildenafil. In the subdomain of time concern of the Psychological and Interpersonal Relationship Scales-Short Form, the score for tadalafil was significantly lower than that for others.
CONCLUSIONS: Our findings support the hypothesis that Japanese patients with erectile dysfunction have high sexual self-confidence, spontaneity and low time concerns when taking tadalafil. These characteristics of tadalafil could be associated with high patient satisfaction and high preference.
© 2014 The Japanese Urological Association.

Entities:  

Keywords:  Psychological and Interpersonal Relationship Scales-Short Form; erectile dysfunction; inhibitors of phosphodiesterase type 5 inhibitors; internet survey

Mesh:

Substances:

Year:  2014        PMID: 24661267     DOI: 10.1111/iju.12429

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  2 in total

Review 1.  A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil.

Authors:  Jeffery D Evans; Stephen R Hill
Journal:  Patient Prefer Adherence       Date:  2015-08-12       Impact factor: 2.711

2.  Degree of Planning of Sexual Intercourse Among Men From China, Japan, and Taiwan Taking Medication for Erectile Dysfunction: Findings of an Observational, Cross-Sectional Survey.

Authors:  Bang-Ping Jiann; Koichi Nakajima; Sonali Dighe; Chad D Harshman-Smith; Tarek A Hassan
Journal:  Sex Med       Date:  2018-12-03       Impact factor: 2.491

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.